Hussman Strategic Advisors, Inc. Sonoma Pharmaceuticals, Inc. Transaction History

Hussman Strategic Advisors, Inc.

  • $386 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021
SELL
$5.23 - $8.89 $16,213 - $27,559
-3,100 Closed
0 $0
Q2 2021

Aug 03, 2021
BUY
$7.12 - $9.15 $22,072 - $28,365
3,100 New
3,100 $23,000

Others Institutions Holding SNOA

# of Institutions
1
Shares Held
2.27K
Call Options Held
0
Put Options Held
0
View Full List

About Sonoma Pharmaceuticals, Inc.

SNOA Quotes by TradingView
  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8.84M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email